Protection against Plasmodium falciparum malaria by PfSPZ Vaccine

JCI Insight

Volumn 2, Issue 1, 2017, Pages

  Epstein, Judith E ^a   Paolino, Kristopher M ^b   Richie, Thomas L ^c   Sedegah, Martha ^a   Singer, Alexandra ^a   Ruben, Adam J ^c   Chakravarty, Sumana ^c   Stafford, April ^b   Ruck, Richard C ^b   Eappen, Abraham G ^c   Li, Tao ^c   Billingsley, Peter F ^c   Manoj, Anita ^c   Silva, Joana C ^d   Moser, Kara ^d   Nielsen, Robin ^b   Tosh, Donna ^b   Cicatelli, Susan ^b   Ganeshan, Harini ^a   Case, Jessica ^e   Padilla, Debbie ^c   Davidson, Silas ^b   Garver, Lindsey ^b   Saverino, Elizabeth ^c   Murshedkar, Tooba ^c   Gunasekera, Anusha ^c   Twomey, Patrick S ^b   Reyes, Sharina ^a   Moon, James E ^b   James, Eric R ^c   Natasha, K C ^c,f   Li, Minglin ^c,f   Abot, Esteban ^a   Belmonte, Arnel ^a   Hauns, Kevin ^b   Belmonte, Maria ^a   Huang, Jun ^a   Vasquez, Carlos ^a   Remich, Shon ^b   Carrington, Mary ^a   Abebe, Yonas ^c   Tillman, Amy ^e   Hickey, Bradley ^b   Regules, Jason ^b   Villasante, Eileen ^a   Kim Lee Sim, B ^c,f   Hoffman, Stephen L ^c   more..

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c SANARIA INC   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e University of Iowa   (United States)

^f Protein Potential LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014580951     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.89154     Document Type: Article

References (32)

1. World Malaria Report 2015. World Health Organization. http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/. Accessed November 28, 2016.
2. Hoffman SL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002;185(8):1155–1164.
3. Roestenberg M, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 2009;361(5):468–477.
4. Seder RA, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013;341(6152):1359–1365.
5. Hoffman SL, et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin. 2010;6(1):97–106.
6. Epstein JE, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science. 2011;334(6055):475–480.
7. Ishizuka AS, et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat Med. 2016;22(6):614–623.
8. Malaria Vaccine Funders Group. Malaria Vaccine Technology Roadmap. World Health Organization. http://www.who.int/immunization/topics/malaria/vaccine_roadmap/TRM_update_nov13.pdf ?ua=1. Accessed November 28, 2016.
9. Egan JE, et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 1993;49(2):166–173.
10. Steward treated for malaria in Turkey’s west, days after stewardess dies of same disease. Hurriyet Daily News. http://www.hurriyetdailynews.com/steward-treated-for-malaria-in-turkeys-west-days-after-stewardess-dies-of-same-disease-.aspx?pageID=238&nID=84450&NewsCatID=341. Published June 24 2015. Accessed November 28, 2016.
11. Hayward, S. A British Airways flight attendant has died of malaria after a long-haul flight to Africa. Daily Mirror. http:// www.mirror.co.uk/news/uk-news/british-airways-stewardess-dies-after-6094210. Published July 18, 2015. Accessed November 28, 2016.
12. Murphy JR, Baqar S, Davis JR, Herrington DA, Clyde DF. Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection. J Clin Microbiol. 1989;27(7):1434–1437.
13. Bejon P, et al. Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J Infect Dis. 2005;191(4):619–626.
14. Nussenzweig V, Nussenzweig RS. Circumsporozoite proteins of malaria parasites. Cell. 1985;42(2):401–403.
15. Hoffman SL, et al. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. N Engl J Med. 1986;315(10):601–606.
16. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987;330(6149):664–666.
17. Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A. 1988;85(2):573–576.
18. Doolan DL, Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol. 2000;165(3):1453–1462.
19. Weiss WR, Jiang CG. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS One. 2012;7(2):e31247.
20. Kumar S, et al. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature. 1988;334(6179):258–260.
21. Hoffman SL, et al. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science. 1989;244(4908):1078–1081.
22. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 1989;341(6240):323–326.
23. Weiss WR, et al. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med. 1990;171(3):763–773.
24. Neafsey DE, et al. Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med. 2015;373(21):2025–2037.
25. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet. 2008;371(9616):923–931.
26. Luke TC, Hoffman SL. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol. 2003;206(Pt 21):3803–3808.
27. Walliker D, et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science. 1987;236(4809):1661–1666.
28. Burkot TR, Williams JL, Schneider I. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Trans R Soc Trop Med Hyg. 1984;78(3):339–341.
29. Kamau E, Alemayehu S, Feghali KC, Saunders D, Ockenhouse CF. Multiplex qPCR for detection and absolute quantification of malaria. PLoS One. 2013;8(8):e71539.
30. Kamau E, et al. Sample-ready multiplex qPCR assay for detection of malaria. Malar J. 2014;13:158.
31. Ponnudurai T, Leeuwenberg AD, Meuwissen JH. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Trop Geogr Med. 1981;33(1):50–54.
32. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75(4):800–802.